Intervention trials Community-based studies An early intervention trial of selenium supplementation was undertaken in China in 1985 among a general population of 130,471 individuals living in a high-risk area for viral hepatitis B infection and liver cancer
Anti-inflammatory signaling (KPV): Crosses cellular membranes via the PepT1 transporter and inhibits NF-B translocation, reducing TNF- and IL-1 production
The treatment process may vary depending on the symptoms, such as brain fog, numbness, exhaustion, or a slow metabolism
The formulation also acts as supportive therapy in conditions like anemia, lethargy and metabolic disorders
GHK-Cu 50 mg Peptide (Research Grade) $129.00 Out of stock Guarantee safe & secure checkout Description Key features: Naturally occurring copper peptide complex found in human plasma, saliva, and urin Lyophilised for stability, easy reconstitution Suitable for subcutaneous administration in approved research protocols Stored refrigerated at 28C after delivery Suggested reconstitution (research use only) Reconstitute 50 mg with 5 mL bacteriostatic water to yield 10,000 mcg/mL
